{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"IQVIA Holdings, Inc."},"Symbol":{"label":"Symbol","value":"IQV"},"Address":{"label":"Address","value":"4820 EMPEROR BOULEVARD, DURHAM, North Carolina, 27703, United States"},"Phone":{"label":"Phone","value":"+1 919 998-2000"},"Industry":{"label":"Industry","value":"Biotechnology: Commercial Physical & Biological Resarch"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"IQVIA Holdings Inc is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The Research & Development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The Technology & Analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business."},"CompanyUrl":{"label":"Company Url","value":"https://www.iqvia.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Ari Bousbib","title":"Chairman, President & Chief Executive Officer"},{"name":"James Grant Berkshire","title":"Executive VP-Global Technology & Operations"},{"name":"Jeffrey A. Spaeder","title":"Chief Medical & Scientific Officer"},{"name":"Karl Guenault","title":"Chief Information Officer & Senior Vice President"},{"name":"W. Richard Staub","title":"President-Research & Development Solutions"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}